Table 3.
Patient demographics after propensity score matching.
| Trachelectomy | Hysterectomy | SD | |
|---|---|---|---|
| Characteristic | n=179 | n=179 | |
| Age (years) | 0.013 | ||
| ≥ 40 | 13 (7.3%) | 14 (7.0%) | |
| < 40 | 166 (92.7%) | 165 (93.0%) | |
| Ethnicity | 0.015 | ||
| White | 117 (65.4%) | 115 (64.2%) | |
| Black | 5 (2.8%) | 5 (2.8%) | |
| Hispanic | 45 (25.1%) | 46 (25.7%) | |
| Others | 12 (6.7%) | 13 (7.3%) | |
| Marital status | 0.050 | ||
| Single | 83 (46.4%) | 77 (43.0%) | |
| Married | 79 (44.1%) | 79 (44.1%) | |
| Others | 17 (9.5%) | 23 (12.8%) | |
| Registry Area | 0.055 | ||
| West | 100 (56.8%) | 104 (57.1%) | |
| Central | 22 (12.5%) | 25 (13.7%) | |
| East | 54 (30.7%) | 53 (29.1%) | |
| Year at diagnosis | 0.072 | ||
| 1998–2002 | 23 (12.8%) | 25 (14.0%) | |
| 2003–2008 | 69 (38.5%) | 74 (41.3%) | |
| 2009–2014 | 87 (48.6%) | 80 (44.7%) | |
| Stage | 0.009 | ||
| IA1 | 43 (24.0%) | 37 (20.7%) | |
| IA2 | 45 (25.1%) | 54 (30.2%) | |
| IA NOS | 2 (1.1%) | 0 | |
| IB1 (≤2 cm) | 89 (49.7%) | 88 (49.2%) | |
| Histology | 0.009 | ||
| Squamous | 88 (49.2%) | 89 (49.7%) | |
| Adenocarcinoma | 79 (44.1%) | 76 (42.5%) | |
| Adenosquamous | 12 (6.7%) | 14 (7.8%) | |
| Grade | 0.036 | ||
| 1 | 38 (21.2%) | 46 (25.7%) | |
| 2 | 72 (40.2%) | 65 (36.3%) | |
| 3 | 28 (15.6%) | 25 (14.0%) | |
| Unknown | 41 (22.9%) | 43 (24.0%) | |
| Pelvic lymphadenectomy | 0.055 | ||
| None | 17 (9.5%) | 20 (11.2%) | |
| Performed | 162 (90.5%) | 159 (88.8%) | |
| Adjuvant radiotherapy | 0.084 | ||
| None | 173 (96.6%) | 170 (95.0%) | |
| Performed | 6 (3.4%) | 9 (5.0%) | |
| Adjuvant chemotherapy | 0.032 | ||
| None/unknown | 174 (97.2%) | 173 (96.6%) | |
| performed | 5 (2.8%) | 6 (3.4%) |
Number (% per column)is shown.
Absolute SD of ≤0.10 indicates a good balance between the two groups.
Abbreviation: NOS, not otherwise specified; and SD, standardized difference.